Altimmune Inc (ALT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
Sales | 5 | 5 | 37 | 362 | 6 |
Gross Profit | 5 | 5 | 37 | 362 | 6 |
Operating Expenses | 26,750 | 26,799 | 33,660 | 22,902 | 18,013 |
Operating Income | -26,745 | -26,794 | -33,623 | -22,540 | -18,007 |
Interest Expense | -1 | 1 | 6 | 29 | -2 |
Other Income | 2,104 | 2,401 | 1,988 | 1,898 | 1,944 |
Pre-tax Income | -24,640 | -24,394 | -31,641 | -20,671 | -16,061 |
Net Income Continuous | -24,640 | -24,394 | -31,641 | -20,671 | -16,061 |
Net Income | $-24,640 | $-24,394 | $-31,641 | $-20,671 | $-16,061 |
EPS Basic Total Ops | -0.35 | -0.34 | -0.55 | -0.39 | -0.32 |
EPS Basic Continuous Ops | -0.35 | -0.34 | -0.56 | -0.39 | -0.32 |
EPS Diluted Total Ops | -0.35 | -0.34 | -0.55 | -0.39 | -0.32 |
EPS Diluted Continuous Ops | -0.35 | -0.34 | -0.56 | -0.39 | -0.32 |
EPS Diluted Before Non-Recurring Items | -0.35 | -0.34 | -0.33 | -0.39 | -0.32 |
EBITDA(a) | $-27,753 | $-27,670 | $-34,204 | $-23,092 | $-18,512 |